Delivery Order SPE2DB22D1103-SPE2DB24FTDA2
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of OFLOXACIN 0.3% EAR DROPS 5ML. The $5,469.25 firm fixed-price delivery order has an ultimate completion date of January 17, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
- The Defense Logistics Agency Troop Support Medical awarded a $1,033 firm fixed price delivery order to Amerisourcebergen Drug Corporation for OFLOXACIN 0.3% ear drops. The place of performance is Conshohocken, Pennsylvania, with a period of performance from September 8-11, 2023. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will provide the requested pharmaceutical products to the Defense Logistics Agency under this contract vehicle. No set aside designation or...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,135.75 contract is for the supply of OFLOXACIN 0.3% EAR DROPS 5ML, a pharmaceutical product, with a completion date of July 26, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,389.60 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of 0.3% ofloxacin ear drops in a 10mL size. This order was not set aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. Under this IDC,...
- This federal contract award is for the delivery of OFLOXACIN 0.3% EAR DROPS 10ML to the Defense Logistics Agency (DLA). The contract, valued at $1,787.22, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of December 19, 2024. This award is not associated with any set-aside designation, indicating open competition....
- This federal contract award, valued at $3,793.07, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of OFLOXACIN 0.3% EAR DROPS 5ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of February 18, 2025. No set-aside designation was used for this award. In addition to this specific delivery order, AmerisourceBergen holds a significant Indefinite...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $1,640.84 contract is for the delivery of Ofloxacin 0.3% ear drops, 5ml, to support DLA Troop Support Medical programs and facilities. No set aside designation was used. Amerisourcebergen Drug Corp, as a prime contractor, has received numerous federal contract...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ofloxacin 0.3% ear drops in 5ML units under a firm fixed-price contract valued at $2,853.90. The award, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of OFLOXACIN 0.3% EAR DROPS 10ML, a pharmaceutical product, with a ceiling value of $3,486.18. The contract was awarded on September 27, 2022, with a completion date of September 28, 2022, and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
- The Defense Logistics Agency awarded a $158 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561661389 units of ofloxacin 0.3% ear drops. The place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between August 1-2, 2023. As a major distributor of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen will fulfill this order to supply the antibiotic ear drops in support of the...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB24FTDA2Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of OFLOXACIN 0.3% EAR DROPS 5ML, a pharmaceutical product, with a potential value of $1,557.96. The contract is a firm fixed price delivery order with a completion date of December 21, 2023. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of providing pharmaceutical products and medical supplies to DLA Troop Support Medical facilities to support military treatment programs. No set-aside designation was used for this award, which will be performed at Amerisourcebergen's corporate headquarters in Conshohocken, Pennsylvania.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 12/20/23 |